AVB vs PLX · P/E 23, rev $2.91B vs P/E 31, rev $53.6M
AvalonBay Communities Inc (AVB) versus Protalix Biotherapeutics Inc (PLX) — a side-by-side from cached financials, not a winner call.
AvalonBay Communities Inc (AVB) is a reit - residential company listed on US.
Protalix Biotherapeutics Inc (PLX) is a biotechnology company listed on US.
Latest reported AVB revenue for 2024-12-31 was $2.91B. Net income was $1.08B. Revenue was up 5.3% from 2023-12-31 to 2024-12-31. AVB currently screens at market cap $26.84B and trailing P/E 23.4.
Latest reported PLX revenue for 2026-06-30 was $53.6M. Net income was $22.1M. Revenue was up 59.0% from 2026-03-31 to 2026-06-30. PLX currently screens at market cap $122.6M and trailing P/E 30.8.
AVB currently screens at market cap $26.84B and trailing P/E 23.4. PLX currently screens at market cap $122.6M and trailing P/E 30.8.
Not investment advice. Open the AVB and PLX stock pages for the full models.
Not investment advice.